1. Home
  2. CRAI vs AMPH Comparison

CRAI vs AMPH Comparison

Compare CRAI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRAI
  • AMPH
  • Stock Information
  • Founded
  • CRAI 1965
  • AMPH 1996
  • Country
  • CRAI United States
  • AMPH United States
  • Employees
  • CRAI N/A
  • AMPH N/A
  • Industry
  • CRAI Other Consumer Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRAI Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • CRAI Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • CRAI 1.2B
  • AMPH 1.1B
  • IPO Year
  • CRAI 1998
  • AMPH 2014
  • Fundamental
  • Price
  • CRAI $187.07
  • AMPH $23.30
  • Analyst Decision
  • CRAI Buy
  • AMPH Hold
  • Analyst Count
  • CRAI 1
  • AMPH 5
  • Target Price
  • CRAI $224.00
  • AMPH $38.00
  • AVG Volume (30 Days)
  • CRAI 64.5K
  • AMPH 566.0K
  • Earning Date
  • CRAI 05-01-2025
  • AMPH 05-07-2025
  • Dividend Yield
  • CRAI 1.04%
  • AMPH N/A
  • EPS Growth
  • CRAI 21.18
  • AMPH N/A
  • EPS
  • CRAI 7.40
  • AMPH 2.77
  • Revenue
  • CRAI $697,476,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • CRAI $6.59
  • AMPH $1.48
  • Revenue Next Year
  • CRAI $4.80
  • AMPH $5.97
  • P/E Ratio
  • CRAI $25.57
  • AMPH $8.47
  • Revenue Growth
  • CRAI 8.49
  • AMPH 8.05
  • 52 Week Low
  • CRAI $133.54
  • AMPH $22.64
  • 52 Week High
  • CRAI $214.01
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • CRAI 67.31
  • AMPH 39.25
  • Support Level
  • CRAI $164.16
  • AMPH $23.30
  • Resistance Level
  • CRAI $192.03
  • AMPH $25.36
  • Average True Range (ATR)
  • CRAI 6.70
  • AMPH 0.86
  • MACD
  • CRAI 3.04
  • AMPH 0.10
  • Stochastic Oscillator
  • CRAI 87.43
  • AMPH 1.66

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: